CMS has advised Discovery Life Sciences, a US-based bio-specimen, genomic sequencing, cell, and immunohistochemistry services firm, on its acquisition of East West Biopharma, a Ukraine-based human bio-specimen solutions organization.
According to CMS, “the acquisition builds on Discovery’s existing capability and creates the largest network of clinical collection sites in Europe, advancing its position as the global market leader in bio-specimen procurement.”
CMS’s team included Managing Partner Graham Conlon, Partners Tetyana Dovgan and Olga Belyakova, Counsels Olga Shenk and Kateryna Chechulina, Senior Associates Viktoriia Stavchuk, Nataliya Nakonechna, Vitalii Mainarovych, Mariana Saienko, and Orest Matviychuk, Associates Louise Cakar, Mykola Heletiy, Roman Hryshyn-Hryshchuk, Vladyslav Kurylko, and Glib Bukharin, Lawyers Ihor Pavliukov, Oleksandr Sytnyk, Sergiy Kulikov, Ivan Pshyk, Diana Pysarenko, and Olga Stetsenko, and Trainee Denys Hatseniuk.
CMS did not reply to our inquiry on the matter.
